Rebecca Prince

Dr. Rebecca Prince

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RPRebecca Prince
Rebecca Prince
AYAnthony Soung Yee
Anthony Soung Yee
LPLaura Parente
Laura Parente
KEKatherine A Enright
Katherine A Enright
EGEva Grunfeld
Eva Grunfeld
MKMonika K Krzyzanowska
Monika K Krzyzanowska
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Cancer patients receiving chemotherapy have high symptom needs that can negatively impact quality of life and healthcare utilization. Chemotherapy-related toxicities usually occur between ambulatory visits to the oncology clinic and result in high rates of unplanned acute care visits, likely reflecting of suboptimal management of these toxicities. Objective: To design a prototype tool to facilitate remote management of chemotherapy-related toxicities to address this gap in care. Methods: User needs were assessed using a participatory, user-centered design methodology that included ethnographic interviews and focus groups, then analyzed using thematic analysis. Participants included oncology patients, caregivers, and health care providers (HCPs) including medical oncologists, oncology nurses, primary care physicians and pharmacists. Overarching themes informed development of a web-based prototype, which was further refined over 2 rounds of usability testing with end-users. Results: Overarching themes were derived from needs assessments which included 14 patients, 1 caregiver, and 12 HCPs. Themes common to both patients and HCPs included: gaps and barriers in current systems, need for decision aids, improved communication and options in care delivery, secure access to credible, timely information, and integration into existing systems. Additionally, patients identified missed opportunities, care not meeting their needs, feeling overwhelmed and anxious, and wanting to be more empowered. HCPs identified accountability for patient management as an issue. These themes informed development of a web-based prototype (“bridges”), which included toxicity tracking, self-management advice, and HCP communication functionalities. Usability testing with 11 patients and 11 HCPs was generally positive; however, identified challenges included tool integration into existing workflows, need for standardized toxicity self-management advice, issues of privacy and consent, and patient-tailored information. Conclusions: A web-based tool integrating just-in-time self-management advice and HCP support into routine care may address gaps in systems for managing chemotherapy-related toxicities but attention needs to be paid to implementation issues.

7 October 2021 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MMMitesh P. Mehta
Mitesh P. Mehta
RPRebecca Prince
Rebecca Prince
ZBZeeshan Butt
Zeeshan Butt
BMBryce E. Maxwell
Bryce E. Maxwell
BCBrittni N. Carnes
Brittni N. Carnes
SSSandeep Samant
Sandeep Samant

1 April 2021 in JCO Oncology Practice
Verified
Journal Article
Closed access
MNMichelle Nadler
Michelle Nadler
ARApril A. N. Rose
April A. N. Rose
RPRebecca Prince
Rebecca Prince
LELawson Eng
Lawson Eng
ALAnthony Lott
Anthony Lott
KEKatherine Enright
Katherine Enright
BACKGROUND: People with cancer are at risk for initial, late, and long-term effects of cancer and its treatments. Cancer rehabilitation (CR) focuses on prevention/treatment of these sequelae and optimization of physical, social, and vocational functioning. Our center has a multidisciplinary impairment-driven outpatient CR program, but referrals of patients with GI cancer were low. AIMS: We aimed (for 2019, relative to 2018) (1) to increase CR referrals of patients with GI cancer by 50% and (2) to increase the proportion of referrals coming from oncologists. Balancing measures included inappropriate referrals and cancellations. METHODS: A rapid cycle improvement approach was used to optimize GI referrals to the CR program. Barriers to CR referral were identified through a literature review and informal interviews of GI clinicians. Barriers included (a) knowledge of CR program existence, (b) awareness of the referral process, (c) time, and (d) lack of CR program exposure. The team used Plan-Do-Study-Act (PDSA) cycles every 2 months from January to December 2019 to address barriers. A p-chart was used to analyze the results. RESULTS: PDSA cycles included CR program advertisement, a presentation to GI staff, nurse-led patient identification, patient-facing posters, and clinician thank-you emails. The p-chart showed a 100% relative increase in referral numbers and an improvement in the percentage of patients referred by oncologists from 51% to 75%. There was no significant change in inappropriate referrals or cancellations. CONCLUSION: Through PDSA cycles, we improved the total number of patients with GI cancer and percentage referred by an oncologist to a CR program. Future work will assess sustainability.

2 May 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
GMGordon Taylor Moffat
Gordon Taylor Moffat
ZCZachary Coyne
Zachary Coyne
HAHamzeh Albaba
Hamzeh Albaba
KAKyaw Lwin Aung
Kyaw Lwin Aung
ADAnna Dodd
Anna Dodd
JKJennifer J Knox
Jennifer J Knox
Background: Pancreatic ductal adenocarcinoma (PDAC) presents significant challenges in diagnosis, staging, and appropriate treatment. Furthermore, patients with PDAC often experience complex symptomatology and psychosocial implications that require multi-disciplinary and inter-professional supportive care management from health professionals. Despite these hurdles, the implementation of inter-professional clinic approaches showed promise in enhancing clinical outcomes. To assess the effectiveness of such an approach, we examined the impact of the Wallace McCain Centre for Pancreatic Cancer (WMCPC), an inter-professional clinic for patients with PDAC at the Princess Margaret Cancer Centre (PM). Methods: This retrospective cohort study included all patients diagnosed with PDAC who were seen at the PM before (July 2012–June 2014) and after (July 2014–June 2016) the establishment of the WMCPC. Standard therapies such as surgery, chemotherapy, and radiation therapy remained consistent across both time periods. The cohorts were compared in terms of survival rates, disease stage, referral patterns, time to treatment, symptoms, and the proportion of patients assessed and supported by nursing and allied health professionals. Results: A total of 993 patients were included in the review, comprising 482 patients pre-WMCPC and 511 patients post-WMCPC. In the multivariate analysis, adjusting for ECOG (Eastern Cooperative Oncology Group) and stage, it was found that post-WMCPC patients experienced longer median overall survival (mOS, HR 0.84, 95% CI 0.72–0.98, p = 0.023). Furthermore, the time from referral to initial consultation date decreased significantly from 13.4 to 8.8 days in the post-WMCPC cohort (p < 0.001), along with a reduction in the time from the first clinic appointment to biopsy (14 vs. 8 days, p = 0.022). Additionally, patient-reported well-being scores showed improvement in the post-WMCPC cohort (p = 0.02), and these patients were more frequently attended to by nursing and allied health professionals (p < 0.001). Conclusions: The implementation of an inter-professional clinic for patients diagnosed with PDAC led to improvements in overall survival, patient-reported well-being, time to initial assessment visit and pathological diagnosis, and symptom management. These findings advocate for the adoption of an inter-professional clinic model in the treatment of patients with PDAC.

1 February 2018 in JMIR Preprints
Verified
Preprint
Open access
RPRebecca Prince
Rebecca Prince
AYAnthony Soung Yee
Anthony Soung Yee
LPLaura Parente
Laura Parente
KEKatherine A Enright
Katherine A Enright
EGEva Grunfeld
Eva Grunfeld
MKMonika K Krzyzanowska
Monika K Krzyzanowska
BACKGROUND Cancer patients receiving chemotherapy have high symptom needs that can negatively impact quality of life and result in high rates of unplanned acute care visits. Remote monitoring tools may improve symptom management in this patient population. OBJECTIVE This study aimed to design a prototype tool to facilitate remote management of chemotherapy-related toxicities. METHODS User needs were assessed using a participatory, user-centered design methodology that included field observation, interviews, and focus groups, and then analyzed using affinity diagramming. Participants included oncology patients, caregivers, and health care providers (HCPs) including medical oncologists, oncology nurses, primary care physicians, and pharmacists in Ontario, Canada. Overarching themes informed development of a Web-based prototype, which was further refined over 2 rounds of usability testing with end users. RESULTS Overarching themes were derived from needs assessments, which included 14 patients, 1 caregiver, and 12 HCPs. Themes common to both patients and HCPs included gaps and barriers in current systems, need for decision aids, improved communication and options in care delivery, secure access to credible and timely information, and integration into existing systems. In addition, patients identified missed opportunities, care not meeting their needs, feeling overwhelmed and anxious, and wanting to be more empowered. HCPs identified accountability for patient management as an issue. These themes informed development of a Web-based prototype (bridges), which included toxicity tracking, self-management advice, and HCP communication functionalities. Usability testing with 11 patients and 11 HCPs was generally positive; however, identified challenges included tool integration into existing workflows, need for standardized toxicity self-management advice, issues of privacy and consent, and patient-tailored information. CONCLUSIONS Web-based tools integrating just-in-time self-management advice and HCP support into routine care may address gaps in systems for managing chemotherapy-related toxicities. Attention to the integration of new electronic tools into self-care by patients and practice was a strong theme for both patients and HCP participants and is a key issue that needs to be addressed for wide-scale adoption.